P172 Personalized cancer vaccines based on self-assembling nanoparticles co-delivering peptide antigens and TLR- 7/8 agonists (SNP-7/8a) enhance the breadth and magnitude of anticancer CD8 T cell immunity. The gene discussed is CD8A; the disease is cancer.